Literature DB >> 13918230

Antitumor activity of cytoxan.

K SUGIURA, F A SCHMID, M M SCHMID.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/pharmacology

Mesh：

Substances：

Year:  1961        PMID： 13918230

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  5 in total

1.  [On the binding of cyclophosphamide and cyclophosphamide-metabolites to serum-albumin (author's transl)].

Authors:  G Voelcker; H P Giera; L Jäger; H J Hohorst
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-05-31

2.  Interference of anti-tumor and immunosuppressive effects of cyclophosphamide in tumor-bearing rats. Analysis of factors determining resistance or susceptibility to a subsequent tumor challenge.

Authors:  D Vidović; M Marusić; F Culo
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

3.  The timing of cyclophosphamide therapy in tumor-bearing rats affects the resistance to tumor challenge in survivors.

Authors:  M Marusić; N Allegretti; F Culo
Journal:  Experientia       Date:  1978-10-15

4.  Ideas and reality in the development of cancer chemotherapeutic agents, with particular reference to oxazaphosphorine cytostatics.

Authors:  N Brock
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

5.  [Blood level and urinary excretion of activated cyclophosphamide and its deactivation products in man (author's transl)].

Authors:  T Wagner; D Heydrich; G Voelcker; H J Hohorst
Journal:  J Cancer Res Clin Oncol       Date:  1980-01       Impact factor: 4.553
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.